MA41506A - Procédés de production de virus pour produire des vaccins - Google Patents

Procédés de production de virus pour produire des vaccins

Info

Publication number
MA41506A
MA41506A MA041506A MA41506A MA41506A MA 41506 A MA41506 A MA 41506A MA 041506 A MA041506 A MA 041506A MA 41506 A MA41506 A MA 41506A MA 41506 A MA41506 A MA 41506A
Authority
MA
Morocco
Prior art keywords
production processes
virus production
produce vaccines
vaccines
produce
Prior art date
Application number
MA041506A
Other languages
English (en)
Inventor
Raman Rao
Original Assignee
Takeda Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Vaccines Inc filed Critical Takeda Vaccines Inc
Publication of MA41506A publication Critical patent/MA41506A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32361—Methods of inactivation or attenuation
    • C12N2770/32363—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
MA041506A 2015-02-13 2016-02-11 Procédés de production de virus pour produire des vaccins MA41506A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562116361P 2015-02-13 2015-02-13

Publications (1)

Publication Number Publication Date
MA41506A true MA41506A (fr) 2017-12-19

Family

ID=56615015

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041506A MA41506A (fr) 2015-02-13 2016-02-11 Procédés de production de virus pour produire des vaccins

Country Status (12)

Country Link
US (1) US20180195048A1 (fr)
EP (1) EP3256571B1 (fr)
JP (1) JP6723253B2 (fr)
KR (1) KR20170116140A (fr)
CN (2) CN114107221A (fr)
AU (2) AU2016219122A1 (fr)
CA (1) CA2975881A1 (fr)
HK (1) HK1248759A1 (fr)
MA (1) MA41506A (fr)
PH (1) PH12017501445A1 (fr)
SG (1) SG11201706593SA (fr)
WO (1) WO2016130940A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015148704A1 (fr) 2014-03-25 2015-10-01 Terumo Bct, Inc. Remplacement passif de milieu
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
HUE055862T2 (hu) 2016-04-20 2021-12-28 Centro De Investig Energeticas Készítmények és eljárások PKLR fokozott génexpressziójára
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
AR109564A1 (es) * 2016-09-01 2018-12-26 Takeda Vaccines Inc Métodos para producir enterovirus c para la producción de vacunas
BE1024733B1 (fr) 2016-11-09 2018-06-14 Univercells Sa Matrice de croissance cellulaire
KR102091372B1 (ko) * 2017-02-28 2020-05-27 대한민국 엔테로바이러스 71형 불활화 백신 및 이의 용도
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
JP2020534829A (ja) * 2017-09-27 2020-12-03 ユニバーセルズ エス．エー．Ｕｎｉｖｅｒｃｅｌｌｓ Ｓ．Ａ． ウイルスワクチンなどの生体分子の製造システムおよび製造方法
SG11202002263TA (en) 2017-10-16 2020-04-29 Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency
EP3728549A1 (fr) 2017-12-20 2020-10-28 Univercells Technologies S.A. Bioréacteur et procédés associés
WO2019200167A1 (fr) 2018-04-11 2019-10-17 Rocket Pharmaceuticals, Ltd. Compositions et procédés pour transplantation de cellules souches
TWI846694B (zh) * 2018-05-04 2024-07-01 美商健臻公司 具有過濾系統的灌注式生物反應器
EP3794829A1 (fr) * 2018-05-14 2021-03-24 InterDigital VC Holdings, Inc. Directions d'intra-prédiction adaptatives de forme de bloc pour arbre binaire quaternaire
KR20210108406A (ko) * 2018-12-21 2021-09-02 론자 워커스빌 아이엔씨. 바이러스 벡터의 자동화된 생산
WO2020163329A1 (fr) 2019-02-05 2020-08-13 Corning Incorporated Substrats de culture cellulaire tissés
EP3924469A4 (fr) * 2019-02-15 2022-12-14 Ology Bioservices, Inc. Méthode de production de virus
US11118151B2 (en) 2019-11-05 2021-09-14 Corning Incorporated Fixed bed bioreactor and methods of using the same
KR102696955B1 (ko) * 2019-11-27 2024-08-19 에스케이바이오사이언스(주) 무혈청 배지에서 부유배양이 가능한 신규한 Vero 세포주, 이의 제조 방법 및 상기 신규 세포주를 이용한 백신용 바이러스 제조 방법
CA3180557A1 (fr) * 2020-05-29 2021-12-02 Lorena Lerner Replicons d'arn encapsules et procedes d'utilisation
CN111849870B (zh) * 2020-08-07 2021-07-23 成都柏奥特克生物科技股份有限公司 无血清Vero细胞固定床生物反应器高密度培养工艺
JP2023547618A (ja) * 2020-10-23 2023-11-13 オロジー バイオサーヴィシズ、インク． ウイルスを細胞に感染させるための方法
US12577540B2 (en) 2020-12-10 2026-03-17 Sarepta Therapeutics, Inc. Suspension mode seed train development for adherent cells
CN114990075B (zh) * 2022-04-20 2023-07-14 中国医学科学院医学生物学研究所 一株可适用于人用疫苗细胞基质培养的柯萨奇病毒a组10型疫苗株及其应用
CN114807060B (zh) * 2022-06-23 2022-09-30 北京民海生物科技有限公司 柯萨奇病毒a6型毒株及其免疫原性组合物和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5063852B2 (ja) * 2000-09-25 2012-10-31 ポリマン サイエンティフィック イミューンバイオロジッシュ フォーシュング ゲゼルシャフト ミット ベシュレンクテル ファフツング 生ワクチン及び製造方法
US9051361B2 (en) * 2010-08-17 2015-06-09 National Health Research Institutes Immunogenic compositions and uses thereof
MY185184A (en) * 2013-01-18 2021-04-30 Temasek Life Sciences Laboratory Ltd Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains
CN103215233B (zh) * 2013-04-03 2015-03-25 浙江普康生物技术股份有限公司 用生物反应器扩增肠道病毒71型的优化工艺方法

Also Published As

Publication number Publication date
CN114107221A (zh) 2022-03-01
PH12017501445A1 (en) 2018-01-15
HK1248759A1 (zh) 2018-10-19
AU2022202087A1 (en) 2022-04-14
JP2018506283A (ja) 2018-03-08
EP3256571B1 (fr) 2022-03-30
US20180195048A1 (en) 2018-07-12
EP3256571A4 (fr) 2018-07-25
JP6723253B2 (ja) 2020-07-15
CN107532150A (zh) 2018-01-02
SG11201706593SA (en) 2017-09-28
CA2975881A1 (fr) 2016-08-18
AU2016219122A1 (en) 2017-09-07
KR20170116140A (ko) 2017-10-18
EP3256571A1 (fr) 2017-12-20
WO2016130940A1 (fr) 2016-08-18

Similar Documents

Publication Publication Date Title
MA41506A (fr) Procédés de production de virus pour produire des vaccins
ZA201903906B (en) Phosphoramidates for the treatment of hepatitis b virus
SG11201707663SA (en) Lyophilization of rna
EP3364949A4 (fr) Vaccins anticancéreux
IL255880A (en) Processes for the production of ribaracetam
EP3393508C0 (fr) Procédé de purification du virus zika
HUE059158T2 (hu) Eljárás pridopidin elõállítására
SG11201608605QA (en) Methods and means for enhancing rna production
HUE047041T2 (hu) Eljárás poliéteraminok elõállítására
MA52906A (fr) Procédé de préparation d'amg 416
SG10201911996RA (en) Process to produce modified clay, modified clay produced and use thereof
HUE050974T2 (hu) Eljárás pirimidinszulfamid-származékok elõállítására
GB201521581D0 (en) Methods of purifying nanostructures
ZA201700254B (en) Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids
HUE049170T2 (hu) Eljárás szubsztituált cikloszerinek elõállítására
EP3265120C0 (fr) Procédé
SG11201607098SA (en) Antibody purification process
HUE047756T2 (hu) Eljárás metil-merkaptán elõállítására
SG11201608513WA (en) Novel purification process of gonadotropin
SG11201802755WA (en) Process for purification of methyl methacrylate
LT3155004T (lt) Vakcina, skirta asmeniui su sutrikusiu imunitetu
MA42658A (fr) Procédé de réduction de pathogènes
EP3119573C0 (fr) Procédé de préparation de béton
EP3217965C0 (fr) Proces pharmaceutique
FR3024729B1 (fr) Procede de preparation du trioxane